These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 21497168)

  • 1. Effects of a selective Y2R antagonist, JNJ-31020028, on nicotine abstinence-related social anxiety-like behavior, neuropeptide Y and corticotropin releasing factor mRNA levels in the novelty-seeking phenotype.
    Aydin C; Oztan O; Isgor C
    Behav Brain Res; 2011 Sep; 222(2):332-41. PubMed ID: 21497168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vulnerability to nicotine abstinence-related social anxiety-like behavior: molecular correlates in neuropeptide Y, Y2 receptor and corticotropin releasing factor.
    Aydin C; Oztan O; Isgor C
    Neurosci Lett; 2011 Mar; 490(3):220-5. PubMed ID: 21195134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nicotine-induced anxiety-like behavior in a rat model of the novelty-seeking phenotype is associated with long-lasting neuropeptidergic and neuroplastic adaptations in the amygdala: effects of the cannabinoid receptor 1 antagonist AM251.
    Aydin C; Oztan O; Isgor C
    Neuropharmacology; 2012 Dec; 63(8):1335-45. PubMed ID: 22959963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hippocampal Y2 receptor-mediated mossy fiber plasticity is implicated in nicotine abstinence-related social anxiety-like behavior in an outbred rat model of the novelty-seeking phenotype.
    Aydin C; Oztan O; Isgor C
    Pharmacol Biochem Behav; 2014 Oct; 125():48-54. PubMed ID: 25158103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term effects of juvenile nicotine exposure on abstinence-related social anxiety-like behavior and amygdalar cannabinoid receptor 1 (CB1R) mRNA expression in the novelty-seeking phenotype.
    Aydin C; Oztan O; Isgor C
    Behav Brain Res; 2012 Mar; 228(1):236-9. PubMed ID: 22119710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of acupuncture on anxiety-like behavior during nicotine withdrawal and relevant mechanisms.
    Chae Y; Yeom M; Han JH; Park HJ; Hahm DH; Shim I; Lee HS; Lee H
    Neurosci Lett; 2008 Jan; 430(2):98-102. PubMed ID: 18060697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic oral nicotine administration and withdrawal regulate the expression of neuropeptide Y and its receptors in the mesocorticolimbic system.
    Birdogan A; Salur E; Tuzcu F; Gokmen RC; Ozturk Bintepe M; Aypar B; Keser A; Balkan B; Koylu EO; Kanit L; Gozen O
    Neuropeptides; 2021 Dec; 90():102184. PubMed ID: 34425507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corticotropin-releasing hormone (CRH) mRNA expression in rat central amygdala in cannabinoid tolerance and withdrawal: evidence for an allostatic shift?
    Caberlotto L; Rimondini R; Hansson A; Eriksson S; Heilig M
    Neuropsychopharmacology; 2004 Jan; 29(1):15-22. PubMed ID: 12968131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Locus coeruleus response to single-prolonged stress and early intervention with intranasal neuropeptide Y.
    Sabban EL; Laukova M; Alaluf LG; Olsson E; Serova LI
    J Neurochem; 2015 Dec; 135(5):975-86. PubMed ID: 26333000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo characterization of JNJ-31020028 (N-(4-{4-[2-(diethylamino)-2-oxo-1-phenylethyl]piperazin-1-yl}-3-fluorophenyl)-2-pyridin-3-ylbenzamide), a selective brain penetrant small molecule antagonist of the neuropeptide Y Y(2) receptor.
    Shoblock JR; Welty N; Nepomuceno D; Lord B; Aluisio L; Fraser I; Motley ST; Sutton SW; Morton K; Galici R; Atack JR; Dvorak L; Swanson DM; Carruthers NI; Dvorak C; Lovenberg TW; Bonaventure P
    Psychopharmacology (Berl); 2010 Feb; 208(2):265-77. PubMed ID: 19953226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of CRF mRNA in the Rat Extended Amygdala Following Chronic Cocaine: Sex Differences and Effect of Delta Opioid Receptor Agonism.
    Connelly KL; Unterwald EM
    Int J Neuropsychopharmacol; 2020 Feb; 23(2):117-124. PubMed ID: 31867624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The novel, selective, brain-penetrant neuropeptide Y Y2 receptor antagonist, JNJ-31020028, tested in animal models of alcohol consumption, relapse, and anxiety.
    Cippitelli A; Rezvani AH; Robinson JE; Eisenberg L; Levin ED; Bonaventure P; Motley ST; Lovenberg TW; Heilig M; Thorsell A
    Alcohol; 2011 Sep; 45(6):567-76. PubMed ID: 21145691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased CRF-like and NPY-like immunoreactivity in adult rats exposed to nicotine during adolescence: relation to anxiety-like and depressive-like behavior.
    Slawecki CJ; Thorsell AK; El Khoury A; Mathé AA; Ehlers CL
    Neuropeptides; 2005 Aug; 39(4):369-77. PubMed ID: 16038974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neonatal thyroxine treatment: changes in the number of corticotropin-releasing-factor (CRF) and neuropeptide Y (NPY) containing neurons and density of tyrosine hydroxylase positive fibers (TH) in the amygdala correlate with anxiety-related behavior of wistar rats.
    Yilmazer-Hanke DM; Hantsch M; Hanke J; Schulz C; Faber-Zuschratter H; Schwegler H
    Neuroscience; 2004; 124(2):283-97. PubMed ID: 14980379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methanol extract of semen Ziziphi Spinosae attenuates ethanol withdrawal anxiety by improving neuropeptide signaling in the central amygdala.
    Li LB; Kim YW; Wang YH; Bai L; Zhu XD; Zhao ZL; Lee CW; Jiao Y; Wu T; Cai ZZ; Kim SC; An WG; Yang CH; Cui GC; Zhao RJ
    BMC Complement Altern Med; 2019 Jun; 19(1):147. PubMed ID: 31234859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of neuropeptide Y Y₁ and Y₂ receptors on behavioral despair in a rat model of depression with co-morbid anxiety.
    Morales-Medina JC; Dumont Y; Benoit CE; Bastianetto S; Flores G; Fournier A; Quirion R
    Neuropharmacology; 2012 Jan; 62(1):200-8. PubMed ID: 21803058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of a cannabinoid receptor (CB) 1 antagonist AM251 on behavioral sensitization to nicotine in a rat model of novelty-seeking behavior: correlation with hippocampal 5HT.
    Bhatti AS; Aydin C; Oztan O; Ma Z; Hall P; Tao R; Isgor C
    Psychopharmacology (Berl); 2009 Mar; 203(1):23-32. PubMed ID: 18936914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corticosterone delivery to the amygdala increases corticotropin-releasing factor mRNA in the central amygdaloid nucleus and anxiety-like behavior.
    Shepard JD; Barron KW; Myers DA
    Brain Res; 2000 Apr; 861(2):288-95. PubMed ID: 10760490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurobiological correlates of individual differences in novelty-seeking behavior in the rat: differential expression of stress-related molecules.
    Kabbaj M; Devine DP; Savage VR; Akil H
    J Neurosci; 2000 Sep; 20(18):6983-8. PubMed ID: 10995843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Corticotropin-releasing factor (CRF) sensitization of ethanol withdrawal-induced anxiety-like behavior is brain site specific and mediated by CRF-1 receptors: relation to stress-induced sensitization.
    Huang MM; Overstreet DH; Knapp DJ; Angel R; Wills TA; Navarro M; Rivier J; Vale W; Breese GR
    J Pharmacol Exp Ther; 2010 Jan; 332(1):298-307. PubMed ID: 19843974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.